Literature DB >> 33752804

US Renal Data System 2020 Annual Data Report: Epidemiology of Kidney Disease in the United States.

Kirsten L Johansen, Glenn M Chertow, Robert N Foley, David T Gilbertson, Charles A Herzog, Areef Ishani, Ajay K Israni, Elaine Ku, Manjula Kurella Tamura, Shuling Li, Suying Li, Jiannong Liu, Gregorio T Obrador, Ann M O'Hare, Yi Peng, Neil R Powe, Nicholas S Roetker, Wendy L St Peter, Kevin C Abbott, Kevin E Chan, Ivonne H Schulman, Jon Snyder, Craig Solid, Eric D Weinhandl, Wolfgang C Winkelmayer, James B Wetmore.   

Abstract

Entities:  

Mesh:

Year:  2021        PMID: 33752804     DOI: 10.1053/j.ajkd.2021.01.002

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


× No keyword cloud information.
  60 in total

1.  Cost Effectiveness of Dapagliflozin Added to Standard of Care for the Management of Diabetic Nephropathy in the USA.

Authors:  Tadesse M Abegaz; Vakaramoko Diaby; Fatimah Sherbeny; Askal Ayalew Ali
Journal:  Clin Drug Investig       Date:  2022-05-25       Impact factor: 2.859

2.  Glomerular B7-1 staining: toward precision medicine for treatment of recurrent focal segmental glomerulosclerosis.

Authors:  Chia-Shi Wang; William E Smoyer; Gabriel Cara-Fuentes
Journal:  Pediatr Nephrol       Date:  2022-06-20       Impact factor: 3.714

3.  Impact of kidney size on the outcome of diabetic patients receiving hemodialysis.

Authors:  Min Wang; Hsin-Chiao Hsu; Mei-Ching Yu; I-Kuan Wang; Chien-Chang Huang; Ming-Jen Chan; Cheng-Hao Weng; Wen-Hung Huang; Ching-Wei Hsu; Lan-Mei Huang; Frederick W K Tam; Tzung-Hai Yen
Journal:  PLoS One       Date:  2022-03-31       Impact factor: 3.240

4.  The In-Center Hemodialysis Unit, Yet Another Obstacle to Home Dialysis.

Authors:  Matthew R Lynch; Ankur D Shah
Journal:  Kidney360       Date:  2021-12-30

5.  Changes in Treatment of Patients with Incident ESKD during the Novel Coronavirus Disease 2019 Pandemic.

Authors:  James B Wetmore; Kirsten L Johansen; Jiannong Liu; Yi Peng; David T Gilbertson; Eric D Weinhandl
Journal:  J Am Soc Nephrol       Date:  2021-09-17       Impact factor: 14.978

6.  Long term tolerability and clinical outcomes associated with tocilizumab in the treatment of refractory antibody mediated rejection (AMR) in pediatric renal transplant recipients.

Authors:  Meghan Pearl; Patricia L Weng; Lucia Chen; Aditi Dokras; Helen Pizzo; Jonathan Garrison; Carrie Butler; Jennifer Zhang; Elaine F Reed; Irene K Kim; Jua Choi; Mark Haas; Xiaohai Zhang; Ashley Vo; Eileen Tsai Chambers; Robert Ettenger; Stanley Jordan; Dechu Puliyanda
Journal:  Clin Transplant       Date:  2022-06-12       Impact factor: 3.456

7.  Prognostic Value of Exercise Capacity in Kidney Transplant Candidates.

Authors:  Sean Tan; Yi Wen Thang; William R Mulley; Kevan R Polkinghorne; Satish Ramkumar; Kevin Cheng; Jasmine Chan; John Galligan; Mark Nolan; Adam J Brown; Stuart Moir; James D Cameron; Stephen J Nicholls; Philip M Mottram; Nitesh Nerlekar
Journal:  J Am Heart Assoc       Date:  2022-06-14       Impact factor: 6.106

8.  Pharmacologic Inhibition of Histone Deacetylase 6 Prevents the Progression of Chlorhexidine Gluconate-Induced Peritoneal Fibrosis by Blockade of M2 Macrophage Polarization.

Authors:  Yingfeng Shi; Jinqing Li; Hui Chen; Yan Hu; Lunxian Tang; Xun Zhou; Min Tao; Zexin Lv; Si Chen; Andong Qiu; Na Liu
Journal:  Front Immunol       Date:  2022-06-15       Impact factor: 8.786

9.  Outcome Analysis of Transition From Peritoneal Dialysis to Hemodialysis: A Population-Based Study.

Authors:  Ming-Hsien Tsai; Yun-Yi Chen; Tsrang-Neng Jang; Jing-Tong Wang; Yu-Wei Fang
Journal:  Front Med (Lausanne)       Date:  2022-06-02

10.  Impact of kidney size on mortality in diabetic patients receiving peritoneal dialysis.

Authors:  Chun-Hao Chen; Chao-Yu Chen; Mei-Ching Yu; Jen-Fen Fu; Yi-Chou Hou; I-Kuan Wang; Yu-Hsin Chih; Cheng-Hao Weng; Wen-Hung Huang; Ching-Wei Hsu; Frederick W K Tam; Tzung-Hai Yen
Journal:  Sci Rep       Date:  2021-04-15       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.